2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Rectal Neoplasms
9
Colorectal Neoplasms
6
Stomach Neoplasms
4
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Neoplasms
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thymoma
2
Obesity, Morbid
2
Lung Neoplasms
2
Kidney Neoplasms
2
Genital Diseases, Female
2
Uterine Prolapse
1
Uterine Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Surgery
1
Squamous Cell Carcinoma of Head and Neck
1
Robotic
1
Prostatic Diseases
1
Precancerous Conditions
1
Pelvic Organ Prolapse
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Obesity, Abdominal
1
Interventions
Metformin
3
drospirenone and ethinyl estradiol combination
2
Caloric Restriction
2
cinnulin PF
1
Yoga
1
Ultrasonography
1
Sugars
1
Robotic Surgical Procedures
1
Population Groups
1
Inositol
1
Hysterectomy
1
Hematologic Tests
1
Glucose Tolerance Test
1
Folic Acid
1
Ethinyl Estradiol
1
Doxycycline
1
Diet
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Control Groups
1
Contraceptives, Oral
1
Acupuncture Therapy
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Menstruation Disturbances
×
Robotic Surgical Procedures
×
Clear all
NCT07120945
2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA
Recruiting
70 enrolled